GENE ONLINE|News &
Opinion
Blog

FDA
Regeneron & Sanofi’s Phase 3 Dupixent Data on Children Under Regulatory Review
2020-04-10
Experimental Plasma Treatment for COVID-19 Gets FDA Support
2020-03-26
Japan Approves World’s First Therapy for Metastatic Non–Small Cell Lung Cancer with METex14
2020-03-26
Gilead Requests FDA to Rescind Remdesivir’s Orphan Drug Designation
2020-03-25
Gilead’s Remdesivir Wins FDA’s Orphan Drug Designation for COVID-19 Treatment
2020-03-24
Gilead’s Antiviral Drug, Epclusa gets FDA Nod for Pediatric Hepatitis C
2020-03-22
USFDA Approves Cepheid’s Rapid, Point-of-Care COVID-19 Test
2020-03-21
Abbott’s Homemade Coronavirus Test bags FDA’s Emergency Authorization
2020-03-19
Weekly Cover : Fosun and BioNTech Invest USD 135m for Covid-19 Vaccine
2020-03-19
Eli Lilly Gets FDA Breakthrough Status for Alopecia Drug
2020-03-17
Thermo Fisher’s Coronavirus Detection Kit Gets FDA Emergency Authorization
2020-03-14
Janssen Bags FDA Breakthrough Therapy Designation for Lung Cancer Drug
2020-03-12
Investigational Gene Therapy for Cystinosis Obtains FDA’s Orphan Drug Designation
2020-03-10
GSK’s Trelegy Ellipta, an Advanced Treatment for Asthma & COPD Submitted for EU Approval
2020-03-05
R&D
SCLC Treatment Gets a Boost as PharmaMar’s Lurbinectedin Bags Priority Review Status
2020-02-19
1 19 20 21 22 23 24
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top